![\"\"](\"https:\/\/www.msd.cz\/en\/wp-content\/uploads\/sites\/98\/2026\/09\/ImpactReport_2026-Cover_ImpactReport2026.jpg\")
<\/figure>\n\n\n\nMSD\u2019s newly published Purpose for Progress Impact Report 2025\/2026<\/a> demonstrates how every action we take is driven by a singular purpose: to use the power of leading-edge science to save and improve lives around the world.<\/p>\n\n\n\n We achieved our sustainability goals that were set for completion in 2025, delivering on commitments to advance health access, strengthen employee engagement and inclusion, reduce our environmental footprint and uphold responsible business practices. We\u2019re building on that momentum with an updated set of sustainability targets. <\/p>\n\n\n\n Importantly, we\u2019ve set an access to health goal to reach 100 million people with access solutions that close gaps in care by 2030 \u2014 driven by the dedication of our colleagues and partners to help strengthen health systems from prevention and diagnosis to treatment and ongoing care. <\/p>\n\n\n\n This goal reflects our commitment to addressing systemic barriers that delay access to prevention, limit people\u2019s ability to start treatment or disrupt care. <\/p>\n\n\n\n \u201cOur commitment to access to health is rooted in our purpose to help save and improve lives. This new goal reflects our ambition to close gaps in care, so more people can access timely, quality care where it is needed most.\u201d<\/p>\n\n\n\n Rob Davis<\/strong> Our innovative medicines and vaccines can only make a difference if they reach those who need them. We\u2019re proud to have achieved and exceeded our access to health<\/a> goals for the 2021-2025 period, with:<\/p>\n\n\n\n Future focus<\/em>: We\u2019re proud of our progress advancing access to health, but we aren\u2019t stopping there. As detailed above and in the Purpose for Progress Impact Report 2025\/2026, we\u2019re building on our strong foundation by sharpening our focus on closing gaps in care \u2014 the challenges people face in receiving evidence-based, medically recommended care. <\/p>\n\n\n\n Our new goal to reach 100 million people with access solutions that close gaps in care by 2030<\/strong> builds on our experience and capabilities, and is designed to deliver meaningful, measurable impact for patients and health systems over time. Implementation will be led by functions across our company, working in collaboration with external partners and stakeholders, to drive sustained impact.<\/p>\n\n\n\n MSD\u2019s inclusive<\/a> and innovative culture is key to enabling our colleagues to deliver breakthroughs for all who depend on us. In 2025, we achieved our employee engagement and inclusion goals.<\/p>\n\n\n\n In addition, our commitment to investing in the growth, success and well-being of our people is reflected in initiatives such as: <\/p>\n\n\n\n Future focus<\/em>: Looking ahead, we\u2019ll continue investing in an agile, skills-based team that\u2019s prepared to drive our next wave of scientific innovation. Our new goal reflects a shift to a culture index that provides a more holistic view of the employee experience, reinforcing that a strong culture is an enterprise-wide priority and a foundation for innovation, resilience and long-term value.<\/p>\n\n\n\n We\u2019re committed to reducing our environmental<\/a> footprint. In 2025, we: <\/p>\n\n\n\n Future focus<\/em>: On our path to achieving net-zero GHG emissions across our entire value chain by 2045, we\u2019re actively driving toward our near-term 2030 targets. This includes reducing our Scope 1 and 2 operational emissions by 46% and cutting our Scope 3 value chain emissions by 30%.<\/p>\n\n\n\n Operating with integrity is the foundation of our company. Our 2025 progress included: <\/p>\n\n\n\n Future focus<\/em>: Looking ahead, we\u2019ve set new goals to ensure employees feel empowered to report concerns as we aim to maintain the highest standards of trust. For example, we\u2019re working to achieve at least 99% global employee completion of enterprise training to ensure understanding of reporting processes and channels through 2030. <\/p>\n\n\n\n Ultimately, these milestones demonstrate that at MSD, our purpose is backed by measurable performance. As we accelerate progress toward our new goals, we remain committed to delivering long-term value for both our business and society by turning scientific innovation into sustainable global impact. <\/p>\n\n\n\n Learn more about our sustainability progress and future commitments in these areas in the Purpose for Progress Impact Report 2025\/2026<\/a>. <\/p>\n\n\n We\u2019re proud to be recognized for our long-standing commitment to operating responsibly<\/span>, including being designated by New<\/span>sweek\/Statista as one of America\u2019s Most Responsible Companies (2025, 2026) and by TIME<\/span>\u00a0<\/span>as one of the World\u2019s Most Sustainable Companies (2026).\u00a0<\/span><\/p>\n<\/div>\n\t\t\t\n ![\"Robert](\"https:\/\/www.msd.com\/wp-content\/uploads\/sites\/9\/2020\/04\/RobDavis_293x212.png?w=293\")
<\/figure>\n<\/div>\n\n\n\n
Chairman and CEO, MSD<\/p>\n<\/div>\n<\/div>\n\n\n\nKey takeaways from this year\u2019s report<\/h2>\n\n\n\n
Access to health <\/h3>\n\n\n\n
\n
\n
Employees <\/h3>\n\n\n\n
\n
Environmental sustainability<\/h3>\n\n\n\n
\n
Ethics and values<\/h3>\n\n\n\n
\n
\n Awards and recognitions <\/h3 >\n\t\t\t\n\t\t\t